<?xml version="1.0" encoding="UTF-8"?>
<p id="Par26">Cervical exfoliated cell samples for HPV DNA testing and cytological evaluation were collected at each study visit. Cytological evaluation was performed at the Cancer Institute of the Chinese Academy of Medical Sciences (CICAMS). And the results were interpreted according to the Bethesda 2001 classification system [
 <xref ref-type="bibr" rid="CR17">17</xref>]. Participants with abnormal results were managed in accordance with the pre-specified algorithms, which had been described previously [
 <xref ref-type="bibr" rid="CR13">13</xref>â€“
 <xref ref-type="bibr" rid="CR15">15</xref>]. Biopsy and excisional treatment specimens were analyzed by a panel consisted of three expert gynecological pathologists. The data for women with CIN diagnoses were reviewed by an independent endpoint committee who had been blinded to make final case assignments.
</p>
